StockNews.com Upgrades Colgate-Palmolive (NYSE:CL) to Buy

Colgate-Palmolive (NYSE:CLGet Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Wednesday.

CL has been the topic of several other research reports. Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research note on Monday, October 28th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price target for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. JPMorgan Chase & Co. raised their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Bank of America raised their price target on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $105.11.

Get Our Latest Research Report on Colgate-Palmolive

Colgate-Palmolive Trading Up 0.7 %

Shares of CL opened at $94.26 on Wednesday. Colgate-Palmolive has a twelve month low of $74.67 and a twelve month high of $109.30. The company has a market cap of $77.01 billion, a P/E ratio of 27.01, a P/E/G ratio of 3.33 and a beta of 0.42. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company’s fifty day simple moving average is $101.80 and its 200-day simple moving average is $98.45.

Insider Activity

In other news, insider Panagiotis Tsourapas sold 14,794 shares of the firm’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares in the company, valued at approximately $529,729.24. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.37% of the company’s stock.

Institutional Trading of Colgate-Palmolive

Institutional investors have recently bought and sold shares of the stock. Main Street Research LLC raised its position in Colgate-Palmolive by 1.5% during the 2nd quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock worth $673,000 after buying an additional 100 shares during the last quarter. Advisor OS LLC raised its position in Colgate-Palmolive by 4.5% during the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after buying an additional 101 shares during the last quarter. BLB&B Advisors LLC raised its position in Colgate-Palmolive by 2.5% during the 2nd quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock worth $421,000 after buying an additional 104 shares during the last quarter. ZWJ Investment Counsel Inc. raised its position in Colgate-Palmolive by 3.1% during the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock worth $349,000 after buying an additional 109 shares during the last quarter. Finally, Hexagon Capital Partners LLC raised its position in Colgate-Palmolive by 9.5% during the 2nd quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock worth $124,000 after buying an additional 110 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.